Faunal behavior in response to near bottom water dynamics in a marine protected area (Cantabrian Sea, southern Bay of Biscay)

A set of lander deployments in a deep marine protected area (MPA; El Cachucho) combining environmental sensors and a baited camera provided insight on the relationship between faunal behavior and oceanographic dynamics. Landers were deployed at different depths, ranging from 500 to 960 m for a period of 24–26 h. A total of 10,989 photographs were downloaded and synchronized using a time code with all the environmental variables recorded (pressure, temperature, salinity, water current, and direction). Total richness accounted for 41 species of different taxonomic groups (21 fishes, 11 crustaceans, 6 echinoderms, and 3 molluscs). The most abundant species were Synaphobranchus kaupii, Mora moro, Phycis blennoides, Helicolenus dactylopterus, and Etmopterus spinax. Arrival times (Tarr) and maximum number of individuals (Nmax) greatly differed among stations. Cluster analysis showed two main faunal groups in relation to depth: those close to the top of the bank and those in the flanks. Species densities were estimated using Priede's equations and compared with those obtained in previous studies using trawl samplers. The relation of species with environmental variables showed high variability depending on the location of the station and the associated variables (depth, current, and water masses). Near-bottom dynamics were consistent with previously known oceanographic patterns at the bank, dominated by background anticyclonic recirculation along the flanks overlaid by strong tidal cycles. Current and hydrography tidally driven phases showed an evident effect in the arrival of species at some locations. Species appeared during specific periods matching the beginning of the flooding phase or end of the ebb phase. Movement rates (cm s−1) were estimated for some invertebrate species, such as crabs (Bathynectes maravigna, 0.66; Pagurus sp., 0.09), the gasteropod Colus gracilis (0.15), and echinoderms (Cidaris cidaris, 0.04; Araeosoma fenestratum, 0.23)

Dengue 3 Epidemic, Havana, 2001

In June 2001, dengue transmission was detected in Havana, Cuba; 12,889 cases were reported. Dengue 3, the etiologic agent of the epidemic, caused the dengue hemorrhagic fever only in adults, with 78 cases and 3 deaths. After intensive vector control efforts, no new cases have been detected

Zoneamento agroecológico do município de Lagoa Seca, PB.

Visa-se, cinzelar, neste estudo um zoneamento em que se considerem os aspectos agrícolas, ecológicos e sociais inerentes ao município de Lagoa Seca, PB, elaborado através da análise dos vários cenários apresentados na área. O uso de um conjunto de recursos, como fotointerpretação, processamento de imagens georreferenciadas, posicionamento por satélites, associados à teoria sistêmica de Bertrand, possibilitou a identificação, delimitação e análise das áreas de uso antrópico, agrícola e das áreas com remanescentes vegetais significativos, que caracterizam o município. Foram elaborados para a área em estudo, arquivos digitais georreferenciados, relativos aos temas: limite municipal, áreas urbanizadas, infra-estrutura viária, rede de drenagem, altimetria, cobertura vegetal natural, uso agrícola do solo e zoneamento. Os resultados obtidos evidenciaram que o município apresenta quatro regiões com aspectos distintos, as quais foram identificadas como regiões agroecológicas, de acordo com o fator que mais se destacou em cada área

Endotoxin tolerance and cross-tolerance in mast cells involves TLR4, TLR2 and FcεR1 interactions and SOCS expression: perspectives on immunomodulation in infectious and allergic diseases

<p>Abstract</p> <p>Background</p> <p>The study of the endotoxin tolerance phenomenon in light of the recently defined roles of mast cells and toll-like receptors as essential components of the innate immune response and as orchestrators of acquired immunity may reveal potentially useful mechanisms of immunomodulation of infectious and allergic inflammatory responses, such as sepsis or asthma. Here we evaluated the phenomenon of direct tolerance of endotoxins, as well as the induction of cross-tolerance and synergism by stimulation with toll-like receptor-2 (TLR2) and FcεR1 agonists, in murine mast cells prestimulated with lipopolysaccharide (LPS). Additionally, we evaluated some stimulatory and inhibitory signaling molecules potentially involved in these phenomena.</p> <p>Methods</p> <p>MC/9 cells and primary bone marrow-derived mast cells obtained from C57BL/6 and TLR4^-/-knock-out mice were sensitized to DNP-HSA (antigen) by incubation with DNP-IgE and were prestimulated with LPS for 18 hr prior to stimulation. Cultures were stimulated with LPS or Pam3Cys-Ser-(Lys)4 3HCl (P3C), a TLR2 agonist, individually or in combination with antigen. The production of IL-6 and TNFα, the phosphorylation of NFκB and p38 MAPK, and the expression of TLR4 and SOCS-1 and -3 were analyzed.</p> <p>Results</p> <p>We found that production of TNFα and IL-6 in murine mast cells that have been pretreated with LPS and challenged with TLR4 (LPS) or -2 (P3C) agonists was reduced, phenomena described as endotoxin tolerance (LPS) and cross-tolerance (P3C), respectively. The expression of TLR4 was not affected by LPS pretreatment. Our results show that the FcεR1 agonist DNP-HSA (antigen) interacts synergistically with LPS or P3C to markedly enhance production of cytokines (TNFα and IL-6). This synergistic effect with LPS and P3C was also attenuated by LPS pretreatment and was mediated by TLR4. These results may be attributed to the reduction in phosphorylation of the mitogen-activated protein kinase (MAPK), p38, and the transcription factor NFκB, as well as to an increase in the expression of the suppressors of cytokine signaling (SOCS)-1 and -3 proteins in LPS-pretreated mast cells.</p> <p>Conclusions</p> <p>These findings can be explored with respect to the modulation of inflammatory responses associated with infectious and allergic processes in future studies.</p

YES1 drives lung cancer growth and progression and predicts sensitivity to dasatinib

Rationale: The characterization of new genetic alterations is essential to assign effective personalized therapies in non–small cell lung cancer (NSCLC). Furthermore, finding stratification biomarkers is essential for successful personalized therapies. Molecular alterations of YES1, a member of the SRC (proto-oncogene tyrosine-protein kinase Src) family kinases (SFKs), can be found in a significant subset of patients with lung cancer. Objectives: To evaluate YES1 (v-YES-1 Yamaguchi sarcoma viral oncogene homolog 1) genetic alteration as a therapeutic target and predictive biomarker of response to dasatinib in NSCLC. Methods: Functional significance was evaluated by in vivo models of NSCLC and metastasis and patient-derived xenografts. The efficacy of pharmacological and genetic (CRISPR [clustered regularly interspaced short palindromic repeats]/Cas9 [CRISPR-associated protein 9]) YES1 abrogation was also evaluated. In vitro functional assays for signaling, survival, and invasion were also performed. The association between YES1 alterations and prognosis was evaluated in clinical samples. Measurements and Main Results: We demonstrated that YES1 is essential for NSCLC carcinogenesis. Furthermore, YES1 overexpression induced metastatic spread in preclinical in vivo models. YES1 genetic depletion by CRISPR/Cas9 technology significantly reduced tumor growth and metastasis. YES1 effects were mainly driven by mTOR (mammalian target of rapamycin) signaling. Interestingly, cell lines and patient-derived xenograft models with YES1 gene amplifications presented a high sensitivity to dasatinib, an SFK inhibitor, pointing out YES1 status as a stratification biomarker for dasatinib response. Moreover, high YES1 protein expression was an independent predictor for poor prognosis in patients with lung cancer. Conclusions: YES1 is a promising therapeutic target in lung cancer. Our results provide support for the clinical evaluation of dasatinib treatment in a selected subset of patients using YES1 status as predictive biomarker for therapy